Kirk Winward, MD
Retina Specialist · Salt Lake City, UTNPI 1962487611
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $2,185 of the $2,748 with a category attached, or 79.5%. US Retina LLC accounts for 79.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $987 and has fallen 94.1% since, to $58 in 2025.
Across 32 payments — averaging $85.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$2K
- Regeneron Healthcare Solutions, Inc.$160
- Genentech USA, Inc.$145
- Astellas Pharma US Inc$121
- AbbVie$101
- Biogen$36
What the payments were for
- Food & beverage$56321%
- Ownership interest$2,18579%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 6 | $2,185 |
| Regeneron Healthcare Solutions, Inc. | 5 | $160 |
| Genentech USA, Inc. | 9 | $145 |
| Astellas Pharma US Inc | 6 | $121 |
| AbbVie(2 entities) | 4 | $101 |
| Biogen | 2 | $36 |
How this compares
$2,748 in reported general payments places this provider in the 60th percentile of 20 retina specialist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 75 | $2,302 |
| MoxifloxacinMoxifloxacin Hcl | 64 | $1,560 |
| Latanoprost | 27 | $202 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $128 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Salt Lake City
- Robert KwunSalt Lake City$334K
- Mitchell GoffSalt Lake City$165K
- James HowardSalt Lake City$14K
- David FaberSalt Lake City$10K
- Rebekah GensureSalt Lake City$5K
- Eric BrintonSalt Lake City$3K
- Gregory BrintonSalt Lake City$1K
- Mano SwartzSalt Lake City$28
- Andrew DavisWest Jordan$4K
- Joshua CarlsonSt George$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.